<DOC>
	<DOCNO>NCT01772706</DOCNO>
	<brief_summary>The purpose study ass randomize , double blind , control , multi-center , phase III study , efficacy low level diode laser ( 100 MW , 658 Nm ) , prevention treatment radiochemotherapy-induced mucositis stage III IV head neck carcinoma .</brief_summary>
	<brief_title>Laser Mucite ORL : Effectiveness Laser Therapy Mucositis Induced Radio-chemotherapy Head Neck Cancer</brief_title>
	<detailed_description>This Phase III randomize , double-blind , multicenter study , two group patient receive radiotherapy concomitant chemotherapy . The patient randomize follow : Arm A = patient receive preventive curative treatment low-energy laser , arm B = control group treat standard local treatment placebo laser ( laser nonfunctional ) . Randomization balance ratio 1 : 1 stratify investigator site . Assessments mucositis , nutritional status , tolerance laser pain perform throughout treatment , week , investigator unaware patient treatment arm . The locoregional control evaluate every 3 month first year , every 6 month 5 year . In case progression , treatment undertaken result report . Radiotherapy : All patient treat conformal radiotherapy without IMRT . The dose adapt treatment indication ( exclusive postoperative ) histological finding case tumoral resection . The radiotherapy prescribe accordance recommendation ICRU 50 report . The dose deliver always 2 Gy per day 5 time week . All beams treat session . A radiological audit conduct beam treat photon first session least week . Chemotherapy : Several chemotherapy concomitant radiotherapy possible : - combination 5-FU Cisplatin - combination 5-FU Carboplatin - Cisplatin alone - Cetuximab alone Dental care : All patient ( except edentulous ) see odontostomatology consultation prior treatment dental care necessary potential production fluorinated gutter During treatment , patient receive oral care The dosimetric study concern cross section , frontal sagittal plane axis lateral beam . Arm A : laser low-level energy functional The material use diode laser 100 mW , wavelength 658 nm . Application make radiotherapy session adapt room ( low light intensity , possibility ENT examination ) grade superior equal 2 stomatitis injury . The application painless , athermal , odorless completely silent . The patient wear glass retinal protection . The operator also wear glass protection allow nevertheless view beams limit . The tumor area macroscopically invade excluded area application . The energetic dose deliver 4 J/cm2 . The duration treatment one determine correspond abacus : [ ( ) = energy ( J/cm2 ) x surface ( cm2 ) / puissance ( W ) ] . The overall duration minute vary depend surface treat The usual dental care prescribe require . Arm B : laser low-level energy nonfunctional The procedure identical one use arm A laser functional . The period application around one minute . All application perform one single operator center . The result assess week another physician ( nurse specifically train ) center , unaware whether patient laser session , order respect `` blinding '' . The assessment detail specifique sheet , specify degree mucositis ( WHO ) , level pain , body weight , type feeding , analgesic treatment take patient , quality life specific questionnaire , possible end treatment therapeutic modification ( number cycle chemotherapy , dosage ) . The laser start soon grade 2 mucositis ( WHO ) observe continue throughout radio-chemotherapy improvement mucositis ( grade &lt; 2 ) .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Stomatitis</mesh_term>
	<mesh_term>Oropharyngeal Neoplasms</mesh_term>
	<criteria>1 . Age 18 75 year 2 . Patient squamous cell carcinoma oral cavity , oropharynx hypopharynx , stage IIIIV , histologically confirm 3 . PS &gt; = 2 4 . Estimated life expectancy great 3 month absence treatment 5 . Concomitant chemotherapy one follow choice prohibit : Cetuximab alone 5FU combined Carboplatin Cisplatin Cisplatin alone Being define follow : serum creatinine &lt; 150 µmol/l creatinine clearance superior equal 55ml/min ( calculate Cockcroft method ) case serum creatinine &gt; 120 µmol/l 6 . Appropriate hematological , renal hepatic function parameter , within 15 day prior randomization , follow result : Hemoglobin &gt; 8g/dL Neutrophils &gt; 1500 x 109 / L Platelets &gt; 100 x 109 / l Total bilirubin &lt; 1.5 time upper limit normal ALT / AST alkaline phosphatase &lt; 2.5 time upper limit normal . 7 . For woman childbearing potential , reliable contraceptive measure ( hormonal contraception , intrauterine device ) require . 1 . Presence malignancy either concomitant diagnose within last five year , except basal cell carcinoma situ carcinoma cervix 2 . Neoadjuvant chemotherapy 3 . Metastatic disease 4 . Previous treatment ENT radiotherapy 5 . Severe hypersensitivity know platinum base agent 6 . Any uncontrolled pathology ( respiratory , cardiac , hepatic renal ) 7 . Pregnant breastfeed woman ( seric urinary pregnancy test must negative time study entry woman childbearing age ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Head neck cancer</keyword>
	<keyword>Low level laser therapy</keyword>
	<keyword>Mucositis induce radiochemotherpy</keyword>
</DOC>